Topadur Pharma AG
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Safety and Tolerability of TOP-N53 Applied on Digital Ulcers in Patients With Systemic Sclerosis (NCT06954597) | Topadur Pharma AG | 2025-02-04 |
Track Topadur Pharma AG automatically
Every clearance here is in the API, with alerts when new ones post.